Mayaro virus (MAYV) is an arbovirus that circulates in Latin America and is emerging as a potential threat to public health. Infected individuals develop Mayaro fever, a severe inflammatory disease characterized by high fever, rash, arthralgia, myalgia and headache. The disease is often associated with a prolonged arthralgia mediated by a chronic inflammation that can last months. Although the immune response against other arboviruses, such as chikungunya virus (CHIKV), dengue virus (DENV) and Zika virus (ZIKV), has been extensively studied, little is known about the pathogenesis of MAYV infection. In this study, we established models of MAYV infection in macrophages and in mice and found that MAYV can replicate in bone marrow-derived macrophages and robustly induce expression of inflammasome proteins, such as NLRP3, ASC, AIM2, and Caspase-1 (CASP1). Infection performed in macrophages derived from Nlrp3–/–, Aim2–/–, Asc–/–and Casp1/11–/–mice indicate that the NLRP3, but not AIM2 inflammasome is essential for production of inflammatory cytokines, such as IL-1β. We also determined that MAYV triggers NLRP3 inflammasome activation by inducing reactive oxygen species (ROS) and potassium efflux. In vivo infections performed in inflammasome-deficient mice indicate that NLRP3 is involved with footpad swelling, inflammation and pain, establishing a role of the NLRP3 inflammasome in the MAYV pathogenesis. Accordingly, we detected higher levels of caspase1-p20, IL-1β and IL-18 in the serum of MAYV-infected patients as compared to healthy individuals, supporting the participation of the NLRP3-inflammasome during MAYV infection in humans.
Arboviruses are one of the public health authorities major concerns, contributing to an increasing awareness of emerging infections worldwide. After the spread of chikungunya virus (CHIKV) to new areas of the globe and the emergence of Zika virus (ZIKV), surveillance systems worldwide are focusing much attention on tracking the next arboviral epidemic [1]. Reported human cases of Mayaro virus (MAYV) infection have been limited to Central and South America, particularly to the regions around the Amazon basin [2–5]. Recent studies revealed the emergence of MAYV recombinants in Brazil and Haiti, and adaptation to a broad host and vector range, placing these countries as high-risk areas for the emergence of MAYV epidemics [6,7]. MAYV belongs to the Togaviridae family and Alphavirus genus, which consists of well-known pathogenic viruses, such as CHIKV, Ross River virus (RRV), Eastern (EEEV), Western (WEEV), and Venezuelan equine encephalitis (VEEV) viruses [8]. Haemagogus mosquitoes have been documented as the main vectors of MAYV, and Aedes aegypti has also been found to be a competent vector, a feature that has alerted authorities to the eminent possibility that MAYV emerge as a global pathogen [1,9]. MAYV is the causative agent of Mayaro fever, a neglected endemic infection that is characterized by nonspecific symptoms such as high fever, rash, arthralgia, myalgia and headache. Similar to CHIKV infection, MAYV is associated with a prolonged arthralgia which can last for months or even years, possibly due to chronic inflammation [10,11]. However, the mechanisms underlying these clinical signs are still not elucidated. Inflammation is a key event during the pathogenesis of many diseases [12–15], and is also the case of those caused by arbovirus [11]. Several studies have characterized the inflammatory process of dengue virus (DENV), CHIKV and ZIKV infection, both in animal models and humans [16–18]. For example, the acute phase of CHIKV infection is associated with high production of inflammatory mediators including IL-6, IL-8, IL-12 and MCP-1, while the chronic phase is associated with other inflammatory cytokines, such as IL-17, IFN-γ and IL-1β [11]. Overall, these cytokines are mainly produced upon recognition of pathogens by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and Nod-like receptors (NLRs) [19,20]. While TLRs are found within cellular and endosomal membranes, NLRs are located in the cytoplasm. They can be activated by different types of pathogens and their associated molecular patterns (PAMPs) [21,22], or by generation of damage-associated molecular patterns (DAMPs) such as potassium efflux, reactive oxygen species (ROS) production, and cathepsin B release [12,23]. Upon activation, NLRs trigger the assembly of cytosolic protein complexes called inflammasomes, which consists of a NLR protein, an adaptor protein, and caspase-1. This enzyme is capable of cleaving pro-IL-1β, producing its mature form (IL-1β), and inducing an inflammatory type of cell death called pyroptosis [23,24]. Although several inflammasomes have been described, the NLRP3 inflammasome is the most studied. It is involved in a wide variety of diseases, such as autoimmunity, cancer and neurodegenerative and infectious diseases [12,23,25]. Arboviral infections, including ZIKV and CHIKV can trigger NLRP3 inflammasome activation in myeloid cells, such as macrophages, leading to an increased production of IL-1β, contributing to pathological inflammatory events that drive the development of both diseases [16,17]. However, whether MAYV infection leads to activation of NLRs and inflammasome assembly has never been reported in vitro or in vivo. MAYV-induced inflammation is likely to play a key role during MAYV pathogenesis, as suggested by a study conducted in patients [11]. Although some studies have evaluated MAYV infection in different models of mice [26,27], the mechanisms governing the pathogenesis of the disease remain largely unexplored. Here, we used primary bone marrow-derived macrophages (BMDMs) to investigate infection and replication of MAYV, we also established an adult mouse model of acute inflammation that allows the evaluation of effects of inflammasomes during the pathogenesis of MAYV. Our study highlights the key role of the NLRP3 inflammasome for pathogenesis of MAYV infection.
Arboviruses such as CHIKV and ZIKV induce inflammasome activation [16,17,28–30]. We thus hypothesized that MAYV could also trigger inflammasome activation in macrophages. As an experimental in vitro model, BMDMs were employed, since these cells are a highly pure population of macrophages (S1A Fig). First, we primed BMDMs derived from C57BL/6 (WT) mice with PAM (3) CSK (4), a TLR2 agonist, for 4 hours and infected the macrophages with different multiplicities of infection (MOI) of CHIKV, ZIKV or MAYV. These three viruses induced IL-1β production (Fig 1A–1C) and LDH release (Fig 1D–1F) in a MOI-dependent manner. MAYV infection in unprimed BMDMs triggered Il1b expression at 3 and 6 hours after infection (S1B Fig), but it did not induce the release of significant levels of mature IL-1β (S1C Fig). Thus, priming with a TLR agonist is required to achieve robust release of IL-1β in macrophage cultures (S1C Fig). It is possible that in vivo, cytokines such as TNF-α are able to prime the cells. We assayed kinetics of IL-1β release by BMDMs and found a time-dependent secretion of IL-1β (S1D Fig). Additionally, we measured the kinetics of viral replication in unprimed and PAM (3) CSK (4) primed BMDMs. The virus has a fast replication cycle, as MAYV RNA levels reach its intracellular peak at 6 to 12 hours, while the extracellular peak is achieved at 12 hours after infection (S1E and S1F Fig). Priming BMDMs did not affect virus infectivity in BMDMs but affected virus output at 24 hours (S1E and S1F Fig). Activation and processing of caspase-1 is a key event during inflammasome activation [23]. Therefore, we stained infected BMDMs with FAM-YVAD, a fluorescent dye that specifically binds to active Caspase-1 (CASP1). By FACS analysis, we gated in the FAM-YVAD+ population (S1G Fig) and found that MAYV induces robust CASP1 activation, as shown by the percentage of FAM-YVAD+ cells and the integrated mean of fluorescence (Fig 1G–1I). We determined that approximately 25% of the BMDMs are infected by MAYV (S2A and S2B Fig) or and 10% with CHIKV (S2D and S2E Fig). Interestingly, we found that approximately 50% of MAYV-infected BMDMs display active caspase-1 (S2C Fig), while 30% of CHIKV-infected BMDMs are FAM-YVAD+ (S2F Fig). Corroborating these data, we performed western blotting and detected the cleaved form of CASP1 (p20) and IL-1β (p17) in the supernatants of MAYV-infected BMDMs (Fig 1J). These data established that MAYV induces CASP1 activation and secretion of IL-1β in infected macrophages. Different inflammasomes, including AIM2 and NLRP3, are activated in response to viral infections [28–35]. To address which inflammasome is activated upon MAYV infection, we assessed the mRNA expression of different inflammasome molecules in BMDMs by qPCR. At 3 and 6 hours post infection, MAYV induced increased expression of Casp1 (Fig 2A), Nlrp3 (Fig 2B), Aim2 (Fig 2C) and Asc (Fig 2D). Next, we tested whether the AIM2 or NLRP3 inflammasomes were required for IL-1β release in macrophages. We observed robust IL-1β production in BMDMs from WT and Aim2–/–mice in response to infection with MAYV, but Nlrp3–/–, Asc–/–and Casp1/11–/–macrophages failed to induce IL-1β secretion (Fig 2E). Importantly, live virus is required for NLRP3 inflammasome activation, since neither heat-inactivated nor UV-irradiated MAYV were capable of inducing IL-1β release (Fig 2F). However, both NLRP3 and Casp1/11 were dispensable for LDH release (S3A Fig). By using western blot we found that NLRP3 was required for CASP1 (p20) and IL-1β (p17) cleavage in response to infection (Fig 2G). Accordingly, NLRP3 was also required for CASP1 activation measured by FAM-YVAD as shown by FACS analysis (Fig 2H–2J). To address whether NLRP3 activation by MAYV influenced viral replication, we infected Nlrp3–/–and Casp1/11–/–BMDMs with MAYV and found that NLRP3 inflammasome does not affect MAYV intracellular or extracellular RNA levels (S3B and S3C Fig). Cellular processes such as potassium efflux and ROS production are known to be important for NLRP3 inflammasome assembly and activation [12,23]. Therefore, we tested whether potassium efflux and ROS are induced by MAYV in BMDMs. MAYV triggered both total (Fig 3A and 3B) and mitochondrial ROS production (Fig 3C and 3D), as shown by the representative histograms and iMFI. In addition, MAYV infection also induced a significant decrease in intracellular potassium in BMDMs (Fig 3E). To address the importance of ROS production in NLRP3 inflammasome activation, we used apocynin, which inhibits NADPH oxidase activity [36]. We found that apocynin effectively blocked ROS production upon infection with MAYV or PMA stimulation (Fig 3F), and this effect resulted in a dose-dependent blockage of IL-1β secretion induced by MAYV infection (Fig 3G). We then tested the effect of K+ efflux on activation of the NLRP3 inflammasome in response to MAYV infection. We treated cells with KCl to increase extracellular K+ and used NaCl as a control [37]. Treatment with NaCl did not interfere in inflammasome activation in response to MAYV infection (Fig 3H). In contrast, KCl (Fig 3I) inhibited IL-1β release upon MAYV infection. Importantly, we measured viral infectivity and replication upon stimulation with the different treatments used and found that neither apocynin, nor NaCl or KCl affected viral infectivity at 1 hour (Fig 3J–3L), or viral load at 24 hours (Fig 3M–3O). Taken together, these results demonstrate that potassium efflux and ROS production are necessary for activation of the NLRP3 in response to MAYV infection. Mouse models of CHIKV infection are well established in the literature [38]. Of note, CHIKV injection into the footpad of mice induces acute inflammation, partially mimicking the pathogenesis of the disease in humans [17]. Patients infected by MAYV develop symptoms very similar to CHIKV-infected individuals [10,11,39]. Because of the similarity of clinical signs and previous reports showing that MAYV induce ankle or foot swelling in 4 weeks old C57BL/6 [27] or A129 mice [26], we tested whether MAYV was able to induce inflammation in the footpad of 6–8 weeks old WT C57BL/6 mice. We injected 106 PFU of MAYV into the footpad of C57BL/6 mice, and footpad thicknesses were measured through eight days of infection. Conditioned media was used in mock infections as a negative control and 107 PFU of CHIKV was used as a positive control. The magnitude of inflammation for both viruses was very similar, with the peak of MAYV-induced swelling at 5 to 6 days of infection (Fig 4A and 4B). We also performed the von-Frey test, which measures the mechanical withdrawal threshold, to assay pain in mice infected with MAYV. The results show that mice felt pain after 1 day of infection, until the end of the experiment at day 8 post infection (Fig 4C). The kinetics of MAYV replication were also measured in the infected footpad, spleen and leg muscle. Although viral copies were considerably high at 1 day after infection in all tissues analyzed, the viral load dropped considerably in the footpad and muscle up to day 10 of infection but remained stable in the spleen (Fig 4D). To evaluate the inflammatory infiltrate at the peak of infection, we infected WT mice with mock or MAYV and performed histological analyses of the footpads. Our results show that MAYV-induced footpad swelling was followed by a strong inflammatory infiltrate, composed primarily of myeloid cells (Fig 4E). Together, these results validate our in vivo model for MAYV-induced acute inflammation. This model resembles the well standardized CHIKV model of infection in the footpad, which is known to mimic infections in patients [17]. The NLRP3 inflammasome has been implicated in the development of CHIKV-induced inflammation in the footpad of injected mice [17]. We injected MAYV at 105 or 106 PFU dose in the footpad of WT and Nlrp3-/- mice and observed that Nlrp3–/–mice had increased footpad swelling compared to WT mice at 5 days post infection with a dose of 105 PFU and at 6 days post infection with a dose of 106 PFU (Fig 5A, 5B and 5C). Representative images of infected WT and Nlrp3–/–mice are shown for both mock and MAYV-infected animals (Fig 5D). We next infected two independently generated Nlrp3–/–mice [40,41] and Casp1/11-/- mice with 105 PFU dose of MAYV and we observed that footpad swelling was significantly higher in these deficient strains compared to WT mice (Fig 5E). Of note, Nlrp3–/–mice showed reduced pain hypersensitivity at earlier time points upon infection but developed pain hypersensitivity similar to WT mice after 5 days of infection (Fig 5F and 5G). Our data indicate that inflammasome signaling is involved with the pathogenesis of this acute model of MAYV infection. Thus, we tested whether the inflammasome plays a role in control of viral replication in vivo. To test this hypothesis, WT and Nlrp3–/–mice were injected with MAYV and euthanized at an early time point (1 day after infection) or at the peak of inflammation (6 days after infection), and virus RNA levels were measured by qPCR. NLRP3 deficiency did not alter viral loads in the footpad (Fig 5H), spleen (Fig 5I) or muscle (Fig 5J) of mice at 1 or 6 days post infection (Fig 5K). We next assessed whether activation of the NLRP3 inflammasome in vivo also occurs upon MAYV infection. We measured IL-1β and IL-18 levels in the supernatants obtained from footpad homogenates of Mock or MAYV-infected WT, Nlrp3-/- and Casp1/11-/- mice. These cytokines are produced upon infection in a NLRP3- and Caspase1/11-dependent manner (Fig 5L and 5M). Taken together, our results suggest that NLRP3 inflammasome activation by MAYV impacts the pathogenesis of an acute in vivo model of infection but does not play a role in viral control in macrophages or in vivo. To further investigate the differences in footpad swelling between WT and Nlrp3-/- mice we performed histopathological analysis of mock and MAYV infected mice. Unexpectedly, the pronounced footpad swelling observed in Nlrp3-/- mice was not followed by a greater infiltration of mononuclear cells and neutrophils in the tissue (Fig 6A and 6B). As expected, we found a robust neutrophil infiltration both in Nlrp3-/- and WT mice infected with MAYV at 6 dpi (Fig 6A and 6B). In addition, MAYV-infected WT mice presented a higher tissue damage score when compared to Nlrp3-/- mice (Fig 6C). In order to assess the inflammatory infiltrate in the joint tissue, we obtained articular lavages from the knees of mock and MAYV-injected mice. Although a considerable number of inflammatory cells was found in MAYV-infected WT mice, NLRP3 deficiency increased cellular infiltration into this joint tissue (Fig 6D). We next addressed the role of this inflammatory platform in the recruitment of specific cellular subsets found in the footpad of MAYV-infected mice (S4 Fig). Although the percentage of neutrophils (CD11b+Ly6G+) (Fig 7A and 7B) and inflammatory monocytes (CD11b+Ly6Chigh) (Fig 7A and 7D) infiltrating the tissue is not affected by the absence of NLRP3 or Casp1/11, all these populations decrease in absolute numbers compared to WT mice (Fig 7C and 7E, respectively). Besides myeloid cells, NK and T lymphocytes were also abundant in the footpad of MAYV-infected mice. Thus, we investigated whether NLRP3 play a role in the recruitment of these populations. We found that MAYV enhanced the percentage (Fig 8A and 8B) and absolute numbers (Fig 8C) of NK cells (CD45+NK1. 1+CD3-) in WT mice and strikingly, the deficiency of NLRP3 and Caspase1/11 promoted an increased infiltration of this subset of cells to the infected tissue. We found that MAYV did not affect the percentage and absolute numbers of T (CD3+) (Fig 8D and 8E), NKT cells (CD45+NK1. 1+CD3+) (Fig 8F and 8G) and B cells (CD19+) (Fig 8H and 8I). In addition, NLRP3 and Casp1/11 do not play a role in the recruitment of these populations. Taken together, our data demonstrate that NLRP3 activation by MAYV is important for recruitment of specific cells, induction of pain and inflammation in a mouse model of Mayaro infection. MAYV infection elicits robust immune responses in patients during acute and convalescent phase of the disease. In addition, secretion of pro-inflammatory immune mediators during the disease has been reported [11]. We evaluated inflammasome-related cytokines levels in sera of confirmed MAYV-infected patients presenting acute febrile illness for five days or less during the early phase of the disease. We found that active Caspase-1 (Caspase-1 p20) levels were higher in sera of infected individuals when compared to healthy controls samples (Fig 9A). Additionally, IL-1β and IL-18 levels in the sera of MAYV patients were higher than those found in healthy individuals (Fig 9B and 9C). These data indicate that MAYV infection is associated with the production of inflammasome-derived components such as Caspase-1 p20, IL-1β and IL-18, supporting our assertion that the NLRP3 inflammasome is important for MAYV clinical setting.
In this study, we evaluated whether MAYV activates the NLRP3 inflammasome and the possible mechanisms involved in the pathogenesis of this acute mouse model. Our findings demonstrate that MAYV triggers NLRP3 activation in macrophages, which have been implicated in the pathogenesis of many viruses [31,32,42–45]. Of note, MAYV induces IL-1β production similar to ZIKV and CHIKV, which are known to trigger the inflammasome [16,17,28–30]. Importantly, we showed that the NLRP3 inflammasome plays an important role during MAYV infection in our mouse model. In addition, the serum of MAYV-infected individuals contains elevated levels of active caspase-1, IL-1β and IL-18, supporting the participation of the NLRP3 inflammasome in the development of MAYV fever in humans. Although the inflammasome is triggered by several viruses and plays an important role in the outcome of infections [31,32,42–45], our study is the first to identify the mechanisms of NLRP3 activation by an alphavirus. The finding that MAYV induces ROS production and potassium efflux, that are important to activate NLRP3, suggest that upon viral entry into the host cell, several PRRs may recognize the virus and affect cellular homeostasis, triggering mitochondrial and other organelle’s damage and inducing pore formation. IL-1β protein secretion was abrogated by inactivated MAYV, indicating that MAYV infection is required for the NLRP3 inflammasome activation. MAYV infection increased the levels of inflammasome-related mRNAs, including Aim2. However, infection did not activate the AIM2 inflammasome, since there was no alteration on secreted IL-1β levels using cells deficient in Aim2. Although MAYV infection induced an increase in steady-state Il1b transcript levels, priming with a TLR agonist prior to infection is needed for significant IL-1β secretion, in agreement with previously published literature with other viruses [45]. Besides cytokine production, cell death is another common consequence of inflammasome activation. However, our LDH release data suggest that cell death is NLRP3-independent. MAYV replication in BMDMs paralleled the kinetics of IL-1β production, which suggests that viral replication cycle itself may account for macrophage death. The cell death mechanism remains to be determined in future studies, since other forms of inflammatory cell death, such as necroptosis, might be triggered by MAYV. Our in vivo model of MAYV acute infection demonstrates that NLR3 inflammasome signaling is associated with pain generation early during infection. This is consistent with previous studies in which NLRP3 inflammasome activation and pain induction in many disease models [46,47]. On the other hand, the finding that NLRP3 signaling was protective for the footpad swelling at the peak of MAYV inflammation was unexpected, since it has been demonstrated that inflammasome blockage is protective against CHIKV infection [48]. However, our FACS data demonstrate that NLRP3 is involved in the recruitment of neutrophils and inflammatory monocytes to the site of MAYV infection, while limiting infiltration of NK cells. Of note, it has been reported that caspase-1-specific antagonist Z-YVAD-FMK treatment leads to a reduction in cutaneous neutrophils recruitment during Semliki Forest virus infection [49]. The influx of inflammatory neutrophils are associated with worsened outcomes during CHIKV infection, since they support CCR2-dependent entry of myeloid cells and increase swelling during CHIKV infection [50]. However, while neutrophils initiate counterproductive responses at mosquito bites, they are required at later stages of disease to prevent mice from succumbing to Semliki Forest virus infection [49], demonstrating that they could have a dual role during alphavirus infections. Interestingly, NK cells were shown to contribute to CHIKV pathogenesis [51], and may explain the increased footpad swelling in NLRP3-deficient mice infected with MAYV. During the acute phase of CHIKV infection there is an increased frequency of cytolytic NK cells in patients [52,53], which could indicate a role in the control of virus-infected target cells. Nevertheless, a greater infiltration of NK cells expressing granzyme B has been correlated with increased edema and footpad swelling during the early acute phase of CHIKV infection in a mouse model [54]. Depletion of NK cells significantly reduced the first peak of swelling during CHIKV infection (3dpi), while not affecting the second peak of swelling (6dpi) of the biphasic pattern of footpad swelling [54]. Although the greater infiltration of NK cells could lead to the increased swelling in NLRP3-deficient mice, we cannot not discard the participation of the inflammasome in edema formation, cell activation and cytokine production, given that we found no roles for NLRP3 in controlling viral titers, a finding consistent with previous studies [48,55]. Inflammasome may present a dual role in alphavirus infections, having protective or deleterious effects. Against other viruses, such as influenza, the NLRP3 activation can be either protective or detrimental depending on the stage of infection and virus load [31,32,55,56]. In addition, mosquito saliva was shown to enhance inflammasome activation and Semliki Forest virus disease [49]. The NLRP3 inflammasome may act alongside other pathways during the development of disease in MAYV-infected patients. We found higher levels of caspase-1, IL-1β and IL-18 in MAYV-infected patients during the acute phase of the disease, showing that the NLRP3-inflammasome might be relevant during MAYV infection in the clinical setting. Recent epidemics of arboviral diseases, such as ZIKV and CHIKV, have emphasized the need for health agencies to anticipate potential emerging pathogens transmitted by arthropods. MAYV infections have been emerging in South America representing a potential threat to public health. There is an urgent need to elucidate the basic processes of MAYV pathogenesis, which is essential to better understand the disease and manage patients. In this scenario, this study advances toward the understanding of the pathogenesis of the disease caused by this virus. We identified the NLRP3 inflammasome as an important pathway related to MAYV pathogenesis, paving the way to future studies exploring the mechanisms governing this disease.
The care of the mice was in compliance with the institutional guidelines on ethics in animal experiments; approved by CETEA (Comissão de Ética em Experimentação Animal da Faculdade de Medicina de Ribeirão Preto, approved protocol number 014/2016). CETEA follow the Brazilian national guidelines recommended by CONCEA (Conselho Nacional de Controle em Experimentação Animal). All proceedings involving human samples and data were approved by the Julio Muller University Hospital ethics committee (process number 1. 164. 656). This institution follows the recommendation from CONEP (Comissão Nacional de Ética em Pesquisa). Samples were obtained with written informed consent from each patient. All participants were adults. Virus strains used in this study comprised MAYV BeAr 20290, CHIKV BzH1 and ZIKV ZikaSPH2015. Genomic sequences of these 3 viruses were deposited in NCBI (National Center for Biotechnology Information) database under the GenBank accession numbers KT754168, KT581023 and KU321639 respectively [57,58]. Virus stocks were produced after infecting Vero cells (ATCC CCL-81) with a MOI of 0. 1 PFU and cultured in DMEM with 2% heat-inactivated FCS, 1% glutamine and 1% Pen-Strep. The supernatant was collected after 2–3 days of infection for MAYV and CHIKV and 5 days for ZIKV, clarified by centrifugation to remove cell debris (5500g) and aliquots were kept at −80°C. Conditioned media used for mock infections was prepared from uninfected Vero cells in a similar manner. Virus stocks were titrated by plaque assay in Vero cells using 10-fold serial dilutions of virus stocks [59]. To inactivate MAYV by ultraviolet light (UV), the virus was dispersed in a tissue culture dish, and a compact UV lamp was placed directly above the dish for 30 minutes. Heat-inactivated MAYV was prepared by incubating the virus at 70°C for 15 minutes. Conditioned media used for mock infections was treated in a similar manner. Virus complete inactivation was verified by the lack of virus plaques after titration by standard plaque assays on Vero cells. The patients samples used were previously described and confirmed for MAYV acute infection by RT-nested-PCR, sequencing, virus isolation and IgM and IgG detection [60,61]. The samples were obtained from May 2015 to March 2016 from patients of Mato Grosso state of Brazil, presenting acute febrile illness with symptoms for five days or less. Patients age presented a median of 40 years old (ranging from 24 to 66 years) and most of them were women (77%). Control serum samples were collected from healthy subjects not infected with arboviruses. Mice used were C57BL/6J mice (JAX 000664), Nlrp3−/− [41], Casp1/11−/− [62], Aim2−/− [63], Nlrc4−/− [64], Asc−/− [65] and Il1r−/− (JAX 003245), all on a C57BL/6 mouse background. When indicated, the JAX Nlrp3−/− (JAX stock #017969) was also used [40]. All mice were bred and maintained under specific-pathogen-free conditions at the Animal Facilities of the Medical School Ribeirão Preto (FMRP-USP). For in vitro experiments bone marrow were collected from 6–12 week old female and/or male mice. The in vivo experiments were conducted using 6–8 week old mice. 6–8 week old male mice (n = 5 mice per group) were inoculated subcutaneously (10 μL) in the ventral side of the footpad with 105 or 106 PFU of MAYV. Mock-infected mice were inoculated with the conditioned media (10 μL). MAYV-induced footpad swelling was assessed every 24 h by measuring height (H) or the height (H) X width (W) of the perimetatarsal area of the hind foot using Kincrome digital vernier calipers. The total area (H x W) was normalized for day 0 measurements. BMDMs were prepared using tibia and femur from 6- to 12-week-old mice as previously described [66]. Briefly, progenitor cells were isolated by flushing femurs and tibia with cold sterile incomplete RPMI 1640 (Gibco). The cells were then cultured in differentiation medium: RPMI 1640 supplemented with 20% heat-inactivated FCS and 30% L-929 cell-conditioned medium (LCCM) as a source of M-CSF. After 7 days in culture, BMDMs were harvested and seeded at the required density for each experiment. An MOI of 5 and 24 hours of infection were used in the experiments in vitro using BMDMs unless otherwise stated in the figure legends. For in vitro cytokine determination, BMDMs were seeded overnight at a density of 2 × 105 cells/well in 48-well plates and prestimulated with 300 ng/ml of PAM (3) CSK (4) (Invivogen) for 4 h, and subsequently infected with MAYV. The cytokines in the supernatants were assayed using a mouse IL-1β ELISA kit (BD Biosciences) according to the manufacturer’s instructions. For in vivo cytokine determination, footpads were processed and the supernatants from total homogenates were obtained. The levels of IL-1β and IL-18 in the homogenates were detected using a mouse IL-1β ELISA kit (BD Biosciences) and a mouse IL-18 ELISA kit (RD-MBL), respectively, according to the manufacturer’s instructions. Detection of IL-1β, IL-18 and Caspase 1 (p20 subunit) in human serum samples was accomplished by using human IL-1β ELISA kit II (BD Biosciences), human total IL-18 (RD) and human caspase-1 ELISA kit (RD) respectively. Total RNA was extracted from 1x106 BMDMs using RNeasy Mini Kit (Qiagen), according to the manufacturer’s instructions. RNA concentrations were determined in a NanoDrop One spectrophotometer (Thermo Fisher Scientific) and 1 μg of the extracted RNA was used for cDNA conversion using the iScriptTM cDNA Synthesis kit (BIO-RAD) in a thermal cycler. Primers used were AscForward: 5’-CCAGTGTCCCTGCTCAGAGT-3’; AscReverse: 5’-TCATCTTGTCTTGGCTGGTG-3’; Casp1Forward: 5’-AGATGCCCACTGCTGATAGG-3’; Casp1Reverse: 5’-TTGGCACGATTCTCAGCATA-3’; Nlrp3Forward: 5’-GTGGTGACCCTCTGTGAGGT-3’; Nlrp3Reverse: 5’-TCTTCCTGGAGCGCTTCTAA-3’; Aim2Forward: 5’-TCTGTCCTCAAGCTAAGCCTCA-3’; Aim2Reverse: 5’-GTGACAACAAGTGGATCTTTCTGTA-3’; Il1bForward: 5’-CCAAGCAACGACAAAATACC-3’; Il1bReverse: 5’-GTTGAAGACAAACCGTTTTTCC-3’; HprtForward: 5’-CAGTCCCAGCGTCGTGATTA-3’; HprtReverse: 5’-GGCCTCCCATCTCCTTCATG-3’. The quantification of Asc, Casp1, Nlrp3 and Il1b produtcs was performed using 50 ng of cDNA, 10 μM of each primer and PowerUp SYBR Green Master Mix (Applied Biosystems) according to the manufacturer’s instructions. The reactions were performed in the QuantStudio 3 Real-Time PCR System (Applied Biosystems). Quantitation was performed by normalizing target gene mRNA levels to Hprt (hypoxanthine guanine phosphoribosyl transferase) levels, and infected sample values are expressed relative to the mean of mock values. Statistical significance between-groups was calculated with ΔCT values that provides the estimates of ΔΔCT values (Log2 fold change) [67,68]. A total of 107 BMDMs were seeded in 6-well plates overnight and then primed with 300 ng/ml PAM (3) CSK (4) (InvivoGen, tlrl-pms) for 4 hours prior to infection with MAYV or mock infection. After 24 hours the supernatants were harvested and proteins were precipitated with ice-cold 50% trichloroacetic acid followed by acetone. Cells were lysed in RIPA buffer (10 mM Tris-HCl, pH 7. 4,1 mM EDTA, 150 mM NaCl, 1% Nonidet P-40,1% deoxycholate and 0. 1% SDS) in the presence of a protease inhibitor cocktail (complete, Roche). Precleared lysates and supernatants were boiled in Laemmli sample buffer, resolved by SDS-PAGE and transferred (Semidry Transfer Cell, Bio-Rad) to a 0. 22-μm nitrocellulose membrane (GE Healthcare). The membranes were blocked in Tris-buffered saline (TBS) with 0. 01% Tween-20 and 5% nonfat dry milk. Rat monoclonal antibody to CASP1 p20 (1: 250, Genentech, 4B4), goat antibody to IL-1β p-17 (1: 200, Sigma Aldrich, I3767), mouse anti-β-Actin (1: 1000, C4, Santa Cruz sc-47778) and specific horseradish peroxidase–conjugated antibodies (1: 3,000, KPL, 14-16-06 and 14-13-06) were diluted in blocking buffer for the incubations. Enhanced chemiluminescence luminol reagent (GE Healthcare) was used for antibody detection. Active CASP1 was measured by fluorochrome inhibitor of caspases assay (YVAD-FLICA, ImmunoChemistry Technologies), a green fluorescent dye that binds specifically to active CASP1. Briefly, 106 BMDMs were seeded in 12-well plates overnight and then infected with MAYV (MOI of 5) or mock infected for 24 hours. As a positive control, we used 20 μM of Nigericin (Sigma-Aldrich) for 40–60 minutes. After that, cells were harvested and stained for 1 h with YVAD-FLICA, following the manufacturer' s instructions. For intracellular virus staining, BMDMs were infected with either MAYV or CHIKV (MOI of 5) or mock-treated for 8 hours. After that, cells were fixed in paraformaldehyde 4% and permeabilized with 0,1% saponin. Cells were incubated for 1 hour with mouse hyperimmune sera to MAYV, CHIKV or isotype control and with FAM-YVAD fluorescent dye, following the manufacturer' s instructions. Mouse hyperimmune sera to MAYV strain BeAr20290 and to CHIKV strain S27-African had their reactivity previously confirmed by indirect immunofluorescence assay [69]. Secondary antibody anti-mouse stained with Alexa-594 was added and incubated for 40 minutes. Cells were then detached from the plates and the data were acquired on a FACS ACCURI C6 flow cytometer (BD Biosciences) and analyzed with FlowJo software (Tree Star). Intracellular concentration of potassium was determined by fluorescence emission of asante potassium green-2 (APG-2, TEFLabs). BMDMs (2×104) were seeded in black, clear-bottom 96-well plates, and treated with PAM (3) CSK (4) for 4 hours, then infected with MAYV (MOI of 5). After 2 hours of infection, BMDMs were incubated with 5 μM APG-2 in RPMI without FBS and phenol red for 30 min. The cells were washed with PBS, and RPMI without phenol red was replaced. Nine images per well were recorded at 40× magnification with the ImageXpress Micro High-Content Imaging System and processed with MetaXpress High-Content Image Acquisition and Analysis (Molecular Devices). To detect intracellular and mitochondrial ROS production, we seeded 106 BMDMs in 12-well plates overnight. Cells were infected with MAYV (MOI of 5) or stimulated with PMA (200 ng/ml) or rotenone (50 μM) for 90 minutes. Next, H2DCFDA (10 μM) and MitoSOX Red dye (2. 5 μM) were added to the cells for 30 min at 37°C, and then they were harvested and analyzed by flow cytometry. The data were acquired on a FACS ACCURI C6 flow cytometer (BD Biosciences) and analyzed with the FlowJo software (Tree Star). BMDMs were primed with 300 ng/ml of PAM (3) CSK (4) (InvivoGen) for 4 hours, treated for 2 hours with 0–50 nM of NaCl or KCl, and then infected with MAYV (MOI of 5). To inhibit NADPH oxidase, cells were treated with 50 or 100 μM apocynin for 1 hour prior to infection. After 24 hours of infection, supernatants were collected and the levels of IL-1β were measured by ELISA (BD Biosciences). The effect of these treatments on virus infectivity and virus production were measured at 1 hour, intracellularly, and 24 hours, extracellularly, after infection with MAYV (MOI of 5) by viral RNA detection by qPCR as described below. BMDMs were seeded overnight in 48-well plates (2x105 cells/well), primed with 300 ng/mL of PAM (3) CSK (4) for 4 hours, and then infected for 24 hours with MAYV, CHIKV or ZIKV in RPMI1640 medium without phenol red, 15 mM HEPES and 2 g/l NaHCO3 supplemented with 2% FBS. At the end of the infection, supernatants were collected and assayed using the CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega) following the manufacturer’s instructions. Cells were incubated with 9% Triton X-100 (Fisher Scientific) for 15 min as a positive control for complete cell lysis. The percentage of LDH release was calculated as (mean OD value of sample / mean OD value of Triton X-100 control sample) × 100, and is shown in the figures as the percentage of cell death compared to Triton X-100. At the times indicated after infection, mice were euthanized and perfused by intracardial injection with PBS. Tissues were dissected, weighed, and homogenized in sterile PBS using a TissueLyser II (Qiagen). The homogenized tissues were diluted 1: 3 in serum-free DMEM (Thermo Fisher Scientific) and seeded onto a monolayer of Vero cells in 24-well plates. The plaque assay was performed as described previously for the quantitation of viral stocks [59]. For viral RNA quantification, aliquots from the same samples used for plaque assay were extracted using QIAamp Viral RNA Mini Kit (QIAGEN) according to the manufacturer' s recommendations. RT-qPCR was performed in one-step using TaqMan Fast Virus 1-Step Master Mix (Applied Biosystems), following the manufacturer' s recommendations. Primers and probe used were designed to detect a 99 bp region of MAYV Nsp2 gene (Nsp2Forward: 5’-GGCATTGCATCCTTTAGCGG-3’; Nsp2Reverse: 5’-GGGAGTAGAACACGGCCATC-3’; Probe: FAM TACCCACAAAGGTCGTGCAGGGCGATACCAAG BHQ1). The reaction was performed in the QuantStudio 3 Real-Time PCR System (Applied Biosystems). Standard curves were generated using titrated virus stocks. qPCR results were normalized to the amount of virus in PFU. Each sample was assayed in duplicate. After 6 days of infection, animals were deeply anesthetized with ketamine and xylazine and perfused through the ascending aorta with PBS, followed by 4% paraformaldehyde (PFA). After perfusion the mouse footpad tissue was immediately removed (skin and muscle). Pieces of the footpad tissue were post-fixed for 24 h in PFA and then replaced with 20% sucrose for 4 days. The tissues were embedded in Tissue-Tek O. C. T. compound and sectioned at 15μm thickness. The specimens were dehydrated in ascending grades of ethyl alcohol, cleared in xylene and stained with Harris haematoxylin and eosin (H&E) for histopathology [70]. Image acquisition was performed by using light microscopy (DM6000B; Leica Microsystems, Buffalo Grove, IL, USA). From each slide, twenty representative photographs were randomly taken (magnification 400x) for analysis of the histological changes. In each high-power field, the degree of tissue damage was determined by a modified score [71]: (1) tissue edema (2) infiltration or aggregation of inflammatory cells, and (3) muscle necrosis. Each item was graded according to the following five-point scale: 0, no damage; 1, minimal damage; 2, mild damage; 3, moderate damage; 4, severe damage. The degree of tissue disease was assessed by the sum of scores ranging from 0 to 12 for each high-power field. In addition, quantification of subcutaneous tissue thickness was performed by histomorphometric analysis using ImageJ software (National Institutes of Health, U. S. A.), and the total number of polymorphonuclear neutrophils infiltrated into the tissues was counted. Knee cavities were surgically opened, and synovial lavage was obtained by flushing the joint cavity with 10μl. Cytospin preparations were acquired by Cytospin 4 (Thermo Scientific) with 70 μl of diluted joint lavage per slide and centrifugation at 200 r. p. m. for 7 min. The slides were air-dried and Giemsa-stained (Laborclin, Pinhais, Brazil) and counted under a light microscope with a 40X objective to determine the total numbers of cells in the lavage fluid. Mice were infected as detailed in In vivo infections and footpad swelling section, and after 5 days of infection for MAYV or 6 days for CHIKV, the animals were sacrificed, and footpads were removed. Footpads homogenates were obtained after 2 hours incubation in collagenase VIII at 1mg/mL and passed thought a 70 μm cell strainer. Cells were counted and plated in 96-well U bottom. Cells were blocked with Fc Block (BD Biosciences) and then stained for flow cytometry analysis. The antibodies employed were anti-CD3ε-PerCP (BioLegend), anti-CD19-APC (BioLegend), anti-NK1. 1-FITC (BioLegend), anti-CD45-APC (BD Biosciences), anti-CD11b-FITC (BioLegend), anti-Ly6G-PerCP (BioLegend) and anti-Ly6C-PE (BioLegend). Cells were also stained with a viability dye (Live/Dead fluorescent dye, Pacific Blue, Life Technologies). Samples were acquired on a FACS Verse flow cytometer (BD Biosciences) and analyzed with FlowJo software (Tree Star). To evaluate the mechanical nociceptive threshold, mice were placed on an elevated wire grid and the plantar surface of the ipsilateral hind paw was stimulated perpendicularly with a series of von Frey filaments (Stoelting, Chicago, IL, USA) with logarithmically increasing stiffness (0. 008–2. 0 g) and the basal mechanical withdrawal threshold was measured one day before infection. Each one of these filaments was applied for approximately 3–4 s to induce a paw-withdrawal reflex. The weakest filament able to elicit a response was taken to be the mechanical withdrawal threshold. The log stiffness of the filament is reported as log10 of the mass of the filament in mg and ranged from 0. 903 (8 mg or 0. 008 g) to 3. 0 (1000 mg or 1 g) [72,73]. Data were plotted and analyzed with GraphPad Prism 8. 1 software (GraphPad, San Diego, California). Log-transformed values for viral load data were used for statistical comparisons. For comparisons of multiple groups, two-way analysis of variance (ANOVA) followed by the Bonferroni' s post test were used. The differences in values obtained for two different groups were determined using an unpaired, two-tailed Student’s t test with a 95% confidence interval. Differences were considered statistically significant when the P < 0. 05.
Viruses transmitted by mosquitoes have recently received huge attention from the media because the epidemics caused by Zika and chikungunya virus rapidly spread to new areas and infected a large number of individuals. Mayaro is a virus transmitted by mosquitoes that circulates in the Caribbean and tropical regions of Latin America. It causes a highly inflammatory disease, called Mayaro fever, and acute disease is often followed by a prolonged arthralgia mediated by chronic inflammation that can last months or years. The spread of Mayaro to urban areas is a major concern by the authorities, given that the virus has potential to cause an epidemic if spread in high-risk areas. Thus, understanding the mechanisms related to the pathogenesis of this infectious agent would be of great value to treat and prevent the disease. Here, we established an adult mouse model of Mayaro infection and demonstrated that the virus activates the NLRP3 inflammasome, which is important to regulate this viral disease. Our study provides molecular targets for a future treatment of Mayaro fever and provides an experimental model to understand the pathology caused by this emerging viral pathogen.
blood cells
medicine and health sciences
immune cells
pathology and laboratory medicine
togaviruses
chikungunya infection
pathogens
animal models of disease
immunology
tropical diseases
microbiology
alphaviruses
animal models
viruses
model organisms
chikungunya virus
rna viruses
signs and symptoms
inflammasomes
experimental organism systems
neglected tropical diseases
research and analysis methods
animal models of infection
immune system proteins
infectious diseases
white blood cells
inflammation
animal studies
proteins
animal cells
medical microbiology
microbial pathogens
mouse models
pathogenesis
immune response
biochemistry
diagnostic medicine
cell biology
viral pathogens
biology and life sciences
cellular types
viral diseases
macrophages
organisms
The NLRP3 inflammasome is involved with the pathogenesis of Mayaro virus